-
-
WOORIEN launches 'MyVet CT Plus': Advanced Veterinary imaging Solution
Lowering CT barriers and improving diagnostic quality Spiral-Linear Technology with Enhanced Power Various and WideFOV with Reduced Scan Time
WOORIEN / 10-26
-
-
Prudential launches first-in-market insurtech solutions MedScreen+ with Reinsurance Group of America
HONG KONG,Oct. 25,2024-- Prudential Hong Kong Limited ("Prudential") is proud to be the first insurer in Hong Kong to launchMedScreen+,an innovative digital underwriting tool developed in c
Prudential Hong Kong Limited / 10-26
-
-
The 2024 Seminar on International Communication of Chinese Medicine and Yi Medicine Big Health Industry Development Promotion Conference Held in Chuxiong, Yunnan Province
CHUXIONG,China,Oct. 24,2024-- The 2024 Seminar on International Communication of Chinese Medicine andYi Medicine Big Health Industry Development Promotion Conference was held in Chuxiong,Yunnan Provin
China Center for International Communication Development (CCICD) / 10-25
-
-
Ampace Shined at All-Energy Australia 2024 - Leading the New Era of All-Scenario Energy Storage through Technology
MELBOURNE,Australia,Oct. 24,2024-- On October 23rd-24th,Ampace made a grand debut at the All-Energy Australia exhibition with its efficient and reliable energy storage solutions. Leveraging its deep e
Ampace / 10-25
-
-
Nature's Miracle Holding Inc. Launches Wholly Owned Subsidiary, NM Rebate Inc. to Complement Core LED Lighting Segment
~ Launch of Rebate Division is Expected to Boost Sales and Margins as Program will Offset the Cost of LED Product Installation ~
Nature's Miracle Holding Inc. / 10-25
-
-
WATT Fuel Cell Earns Frost & Sullivan's 2024 North America Technology Innovation Leadership Award
Award recognizes WATT\'s production of high-efficiency solid-oxide fuel cell systems SAN ANTONIO,Oct. 24,2024-- Frost & Sullivanrecently researched the high-temperature solid-oxide fuel cell (SOF
Frost & Sullivan / 10-25
-
-
Everest Medicines Announces the Launch of VELSIPITY® in the Guangdong-Hong Kong-Macau Greater Bay Area, Offering a New Option for Moderately to Severely Active Ulcerative Colitis Patients
SHANGHAI,Oct. 25,2024-- Everest Medicines (HKEX 1952.HK,"Everest",or the "Company"),a biopharmaceutical company focused on the discovery,clinical development,manufacturing and comm
Everest Medicines / 10-25
-
-
Minghui Pharmaceutical Inc. Announces Positive Topline Results from Phase Ib/II Clinical Trial of MHB018A, a Subcutaneous Single-Domain IGF-1R Antibody, in Patients with Active, Moderate-to-Severe Thyroid Eye Disease (TED)
SHANGHAI,Oct. 22,2024-- Minghui Pharmaceutical,Inc.,a late-stage biopharmaceutical company dedicated to developing transformative medicines in immunology and oncology,today announced positive topline
Minghui Pharmaceutical, Inc. / 10-23
-
-
ViewSonic Unleashes Next-Level Console Gaming with the New X1-4K Pro and X2-4K Pro Projectors
BREA,Calif.,Oct. 22,2024-- ViewSonic Corp.,a global leader in visual solutions,unveils two new projectors—theX1-4K Proand X2-4K Pro. Designed to elevate the console gaming experience,these projector
ViewSonic Corp. / 10-23
-
-
Volvo Cars reports Q3 2024 core operating profit of SEK 5.7 billion
Q3 operating profit (excl. JVs and associates) was SEK 5.7 bn,vs SEK 6.1 bn in Q3 2023 Q3 operating profit was 5.8 bn SEK,vs SEK 4.5 bn in Q3 2023
Volvo Car AB (publ) / 10-23